Abstract:Objective: This study aimed to evaluate the efficacy of α-thalassemia gene testing as a part of an antenatal intervention program over a 10-year period. Methods: All patients underwent α-thalassemia gene testing, which included the analysis of three types of deletions and mutations. Rare α-thalassemia gene testing was performed using Sanger sequencing, multiplex ligation-dependent probe amplification, and sequencing techniques. Prenatal diagnosis was performed in high-risk couples using chorionic villus sampling or amniocentesis. Results: From 2010 to 2019, among the 91,852 patients examined, α-thalassemia mutations were identified in 41.78% of patients. The most frequent α 0 gene mutation was-- SEA , followed by-- THAI . Two rare α 0 -thalassemia gene mutations at -- 32.8 and -- 230 , were also observed. A total of 2,235 high-risk couples were identified, of which 562 were affected, including three with the-- SEA /-- THAI genotype and one with the-- SEA /-- 230 genotype. Additionally, prenatal diagnosis revealed four cases of fetal anemia and/or mild edema, along with two cases of severe fetal edema. Chromosome and gene chip results were normal. Thalassemia gene testing showed an α CS α/α CS α genotype in four patients with anemia and/or mild edema, while two patients with severe fetal edema had one-- SEA /α CS α genotype and one-- SEA /-- GX genotype. Using the cut-off points of 74.6 fL and 24.4 pg as criteria for identifying α 0 -thalassemia carriers and HbH disease, the detection rate of missed diagnoses in high-risk couples is consistent with national guidelines for standards, potentially saving 10,217,700 ¥. Conclusion: Routine molecular testing for α-thalassemia in high-risk prenatal populations effectively prevented severe α-thalassemia births. Despite the high cost, the cutoff points proposed by this study suggest that implementing screening using a new parameter has the potential to reduce current expenses.

Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China

Screening for thalassemia carriers among the Han population of childbearing age in Southwestern of China

Next-generation sequencing improves molecular epidemiological characterization of thalassemia in Chenzhou Region, P.R. China

Next-generation sequencing analysis of the molecular spectrum of thalassemia in Southern Jiangxi, China

Carrier rate of thalassemia among 25,910 high school students in Shaoguan area, China

[Clinical Significance of Screening Thalassemia with High- Throughput Sequencing].

Molecular spectrum and prevalence of thalassemia investigated by third-generation sequencing in the Dongguan region of Guangdong Province, Southern China

AB034. Hemoglobinopathies in China and SEA: Rapid Targeted Deep Sequencing for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies

[Application of Next Generation Sequencing to Screen the Neonatal Thalassemia Genes]

Preimplantation genetic diagnosis of α- and β-double thalassemia combined with aneuploidy screening by next generation sequencing

Prevalence of Thalassemia-carrier of Couples at Childbearing Age and Risk Prediction of Thalassemia

A particular focus on the prevalence of α-thalassemia and β-thalassemia among pregnant women in Changsha County, Hunan Province

Routine antenatal molecular testing for α-thalassemia at a tertiary referral hospital in China: ten years of experience

Screening and Diagnosis of Rare Thalassemia Variants

Comprehensive analysis of thalassemia alleles (CATSA) based on third-generation sequencing is a comprehensive and accurate approach for neonatal thalassemia screening

Early genetic screening uncovered a high prevalence of thalassemia among 18 309 neonates in Guizhou, China

A Pilot Study of Noninvasive Prenatal Diagnosis of Alpha- and Beta-Thalassemia with Target Capture Sequencing of Cell-Free Fetal DNA in Maternal Blood

Rapid Targeted Next-Generation Sequencing Platform for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies

Application of third-generation sequencing for genetic testing of thalassemia in Guizhou Province, Southwest China

Prevalence and molecular characterization of common thalassemia among people of reproductive age in the border area of Guangxi-Yunnan-Guizhou province in Southwestern China

Third-generation sequencing identified a novel complex variant in a patient with rare alpha-thalassemia